Lacamas Laboratories
Generated 5/9/2026
Executive Summary
Lacamas Laboratories is a private, large-scale contract manufacturer of high-quality organic chemicals, headquartered in Camas, Washington, with operations in Portland and Albany, Oregon. Founded in 1985, the company specializes in custom manufacturing for diagnostics and infectious disease applications. Lacamas has recently secured significant defense contracts: a $192.5 million award from the Department of Defense (DoD) to establish domestic manufacturing capabilities, and an additional $86 million defense contract. These awards underscore the company's strategic importance in onshoring critical chemical production, reducing reliance on foreign supply chains. With a strong government backing and a niche in specialty chemicals, Lacamas is positioned for growth, though its private status limits visibility into financials and pipeline. The company's focus on defense and diagnostics provides a stable revenue base, but exposure to government contract cycles introduces some uncertainty.
Upcoming Catalysts (preview)
- Q3 2026Completion of DoD-funded manufacturing expansion80% success
- Q4 2026Additional defense contract awards60% success
- TBDPotential FDA-related commercial production for diagnostics40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)